Hello, I am Janey Willis, ISN Guide to Diabetes. Type 1 Diabetes is an autoimmune disease, and Type 2 Diabetes is caused by risk factors such as lifestyle, ethnicity, age, and pregnancy. The majority of diabetics have Type 2. See Disclaimer.
Diabetes is diagnosed with several different types of glucose blood tests. People who are at high risk for diabetes should have an oral glucose tolerance test, which is significantly better than the fasting plasma glucose test for diagnosing prediabetes. (Also see Autoimmune Diseases and Overview of Diabetes)
How are diabetes and pre-diabetes diagnosed? There are several types of glucose tests used to diagnosis diabetes. National Diabetes Information Clearinghouse.
An early signpost for type 1 diabetes? Those with two or more different kinds of these autoantibodies will eventually develop diabetes, though sometimes not for many years. Science.
Glucose: The Test. The blood glucose test is ordered to measure the amount of glucose in the blood right at the time of sample collection. It is used to detect both hyperglycemia and hypoglycemia and to help diagnose diabetes. LabTestsOnline.
Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM). Children and adolescents with type 1 diabetes are at increased risk for developing other autoimmune diseases, most commonly autoimmune thyroiditis and celiac disease. PubMed, Autoimmun Rev. (Also see Thyroid Diseases and Celiac Disease)
Type 1 diabetes-associated autoimmune diseases: screening, diagnostic principles and management. In this clinical review we present current opinions in terms of diagnosis, management and screening in the most common type 1 diabetes-associated autoimmune diseases. PubMed, Med Wieku Rozwoj. (Also see Thyroid Diseases)
SCLERO.ORG was the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses from 1998 to 2021. It was a grassroots movement from the original Scleroderma from A to Z web site, which was founded by Shelley Ensz. We were a 501(c)(3) U.S.-based public charitable foundation. We closed this web site and our nonprofit agency in April 2021.